Investigation into use of Midazolam during Covid 19 Pandemic

The request is waiting for clarification. If you are Aaron, please sign in to send a follow up message.

Dear Care Quality Commission,

It has come to my attention that in the spring of 2020 when the UK went through its first wave of "covid 19" Midazolam & morphine where used on patients in vast quantities in care homes across the UK

It is alleged that these patients had been transferred from hospital into care homes and put onto end of life care and administered DNR orders and administered these drugs in amounts that would clearly suggest they would die as a direct cause if this medication ( anyone medically trained and issuing these amounts will have been aware )

Disabled patients have also been treated in the same way.

Can you answer a few questions about this matter?

1. Where these people put into end of life care and issued DNR 's as a direct result of their condition with the consent of family members

2. Who in authority made these decisions to use these drugs under these circumstances and gave authority to make these decisions

3. Will a investigation be taken out into this matter as as far as data suggests this amounts to murder and complete falsification of covid death data in order to pursue a narrative for a "covid 19 " pandemic.

Just to point out Midazolam produces respiratory problems and therefore it is believed that due to this convenient side effect of this drug the deaths where misrepresented as covid when in fact they were murdered.

4. Can you provide any evidence to prove that this is not the case and these people needed these medications and where given the correct amounts with consent of relatives and thorough infornation provided about the use of these drugs.

I think this matter is of great urgency to the Public and we should be made aware of the scale of corruption and evil entities within our care system

Please note there is a documentary and evidence to suggest that these accusations are in fact true and it is your duty to convince the public otherwise

All Rights Reserved

Information Access, Care Quality Commission

Dear enquirer

 

Thank you for contacting the Information Access Team at the Care Quality
Commission (CQC).

 

Please accept this automated response as acknowledgement that we have
received your e-mail. 

 

What we do

 

We coordinate responses to requests for recorded information made in
accordance with the Freedom of Information Act 2000 (FOIA), the General
Data Protection Regulation (GDPR), Data Protection Act 2018 (DPA) and the
Environmental Information Regulations 2004 (EIR).

 

If you are making a request for information which falls under these Acts and
regulations

 

We aim to respond to you within three working days with a formal
acknowledgement of your request including a unique reference number and
deadline for our response.

 

Please be as specific as possible in describing the information you want
to request.

 

We have published information on our website explaining [1]how to ask for
official information held by CQC and [2]how to ask for information about
yourself or other people.

 

If you are seeking an update on an existing request

 

The Information Access team is experiencing a higher than usual workload
at present.

 

We are currently working through a backlog of work and will respond to
each request as soon as possible. Thank you for your patience. 

 

Information relating to medical records

 

If you want to request your medical records please contact your GP
surgery, or the organisation that provided your care. CQC does not
routinely hold patient medical records.

 

General enquiries about CQC

 

CQC is the independent regulator of health and adult social care services
in England.

 

There is information about our role published on our website,
[3]www.cqc.org.uk

 

If you have any questions about any aspect of CQC’s work, you can contact
our National Customer Service Centre (NCSC). Please e-mail
[4][email address] or call 03000 616161.

 

Statutory requests for information made under access to information
legislation such as the Data Protection Act 2018, GDPR and the Freedom of
Information Act 2000 should be sent to: [5][CQC request email]

 

How CQC handles and protects your personal data

 

Personal data is processed in accordance with the General Data Protection
Regulation (GDPR) and relevant data protection law. Information on the
processing of personal data by CQC can be found at
[6]www.cqc.org.uk/about-us/our-policies/privacy-statement

 

 

Kind regards

 

The Information Access Team 

 

 

-------------- The contents of this email and any attachments are
confidential to the intended recipient. They may not be disclosed to or
used by or copied in any way by anyone other than the intended recipient.
If this email is received in error, please notify us immediately by
clicking "Reply" and delete the email. Please note that neither the Care
Quality Commission nor the sender accepts any responsibility for viruses
and it is your responsibility to scan or otherwise check this email and
any attachments. Any views expressed in this message are those of the
individual sender, except where the sender specifically states them to be
the views of the Care Quality Commission. Information on how the Care
Quality Commission processes personal data is available here
http://www.cqc.org.uk/about-us/our-polic...

References

Visible links
1. https://www.cqc.org.uk/about-us/our-poli...
2. https://www.cqc.org.uk/about-us/our-poli...
3. http://www.cqc.org.uk/
4. mailto:[email address]
5. mailto:[CQC request email]
6. http://www.cqc.org.uk/about-us/our-polic...

Information Access, Care Quality Commission

Dear Aaron

 

I acknowledge receipt of your correspondence dated 24 January 2022, in
which you made a request for information.

 

Your request is as follows:

 

“It has come to my attention that in the spring of 2020 when the UK went
through its first wave of "covid 19"  Midazolam & morphine where used on
patients in vast quantities in care homes across the UK

 

It is alleged that these patients had been transferred from hospital into
care homes and put onto end of life care and administered DNR orders and
administered  these drugs in amounts that would clearly suggest they would
die as a direct cause if this medication ( anyone medically trained and
issuing these amounts will have been aware )

 

Disabled patients have also been treated in the same way.

 

Can you answer a few questions about this matter?

 

1. Where these people put into end of life care and issued DNR 's as a
direct result of their condition with the consent of family members

 

2. Who in authority made these decisions to use these drugs under these
circumstances and gave authority to make these decisions

 

3. Will a investigation be taken out into this matter as as far as data
suggests this amounts to murder and complete falsification of covid death
data in order to pursue a narrative for a "covid 19 " pandemic.

 

Just to point out Midazolam produces respiratory problems and therefore it
is believed that due to this convenient side effect of this drug the
deaths where misrepresented as covid when in fact they were murdered.

 

4. Can you provide any evidence to prove that this is not the case and
these people needed these medications and where given the correct amounts
with consent of relatives and thorough infornation provided about the use
of these drugs.”

 

CQC will consider your request in accordance with the Freedom of
Information Act 2000 (FOIA).

 

Our statutory deadline for response is 21 February 2022, but we will in
any event endeavour to respond as soon as possible.

 

We will write to you if we are unable to meet this deadline.

 

Please be aware that there may be a delay in providing a response to your
request for information. The Information Access team are experiencing a
higher than usual workload at present due to the pandemic situation. We
are currently working through a backlog of work and will respond to each
request as soon as possible. We thank you for your patience.

 

The information you have requested may be subject to an exemption from the
right to know. Should this occur, we will explain the reasons why when we
respond.

 

Regards

 

On behalf of:

Information Access Team

 

For information about CQC, including contact details, information about
how we use and protect personal data, and how to request information from
us, go to [1]https://www.cqc.org.uk/contact-us

 

-------------- The contents of this email and any attachments are
confidential to the intended recipient. They may not be disclosed to or
used by or copied in any way by anyone other than the intended recipient.
If this email is received in error, please notify us immediately by
clicking "Reply" and delete the email. Please note that neither the Care
Quality Commission nor the sender accepts any responsibility for viruses
and it is your responsibility to scan or otherwise check this email and
any attachments. Any views expressed in this message are those of the
individual sender, except where the sender specifically states them to be
the views of the Care Quality Commission. Information on how the Care
Quality Commission processes personal data is available here
http://www.cqc.org.uk/about-us/our-polic...

References

Visible links
1. https://www.cqc.org.uk/contact-us

Information Access, Care Quality Commission

Dear Aaron

 

I write in response to your request for information dated 24 January 2022.

 

Information Requested:

 

“It has come to my attention that in the spring of 2020 when the UK went
through its first wave of "covid 19"  Midazolam & morphine where used on
patients in vast quantities in care homes across the UK

 

It is alleged that these patients had been transferred from hospital into
care homes and put onto end of life care and administered DNR orders and
administered  these drugs in amounts that would clearly suggest they would
die as a direct cause if this medication ( anyone medically trained and
issuing these amounts will have been aware )

 

Disabled patients have also been treated in the same way.

 

Can you answer a few questions about this matter?

 

1. Where these people put into end of life care and issued DNR 's as a
direct result of their condition with the consent of family members

 

2. Who in authority made these decisions to use these drugs under these
circumstances and gave authority to make these decisions

 

3. Will a investigation be taken out into this matter as as far as data
suggests this amounts to murder and complete falsification of covid death
data in order to pursue a narrative for a "covid 19 " pandemic.

 

Just to point out Midazolam produces respiratory problems and therefore it
is believed that due to this convenient side effect of this drug the
deaths where misrepresented as covid when in fact they were murdered.

 

4. Can you provide any evidence to prove that this is not the case and
these people needed these medications and where given the correct amounts
with consent of relatives and thorough infornation provided about the use
of these drugs.”

 

The Information Access team has now coordinated a response to your
request.

 

CQC has considered your request in accordance with the Freedom of
Information Act 2000 (FOIA).

 

Our first obligation under the legislation is to confirm whether we do or
do not hold the requested information.

 

In accordance with section 1(1) of FOIA we are able to confirm that CQC
does not hold recorded information in relation to this matter.

 

However, We understand that this is a distressing subject, and hope to be
able to answer your questions as helpfully as possible through the
information provided below.

 

Were these people put into end of life care and issued DNR 's as a direct
result of their condition with the consent of family members

 

Although it is not possible to answer questions about individual patients,
CQC undertook a review of how ‘do not attempt cardiopulmonary
resuscitation’ (DNACPR) decisions were being approached in the earlier
stages of the pandemic – shining a light on what contributed to important
conversations around

end of life care being done well, and what may have led to them falling
short. The report, which includes recommendations for providers and a
range of other organisations, such as The Department of Health and Social
Care and NHS England, can be found here:

 

[1]Protect, respect, connect – decisions about living and dying well
during COVID-19 | Care Quality Commission (cqc.org.uk). Our
recommendations include:

o DNACPR decisions need to be recognised as part of wider conversations
about advance care planning and end of life care, and these decisions
need to be made in a safe way that protects people's human rights.
o Clinicians, professionals and workers must have the knowledge, skills
and confidence to speak with people about, and support them in, making
DNACPR decisions.
o People, their families and representatives need to be supported, as
partners in personalised care, to understand what good practice looks
like for DNACPR decisions.

 

Who in authority made these decisions to use these drugs under these
circumstances and gave authority to make these decisions

 

The decision to prescribe a medicine rests with the treating clinician.
 Midazolam and morphine are medicines that have a range of uses.
Clinicians who are able to prescribe these have guidance available to
support them to do so safely and effectively. This includes prescribing
guidance found in the British National Formulary (BNF), for example:
[2]https://bnf.nice.org.uk/drug/midazolam.h.... The
National Institute for Health and Care Excellence (NICE) have also issued
guidance on the prescribing of midazolam for people with COVID-19 who are
at the end of their lives:
[3]https://cks.nice.org.uk/topics/coronavir....

 

Will a investigation be taken out into this matter as as far as data
suggests this amounts to murder and complete falsification of covid death
data in order to pursue a narrative for a "covid 19 " pandemic.

 

Just to point out Midazolam produces respiratory problems and therefore it
is believed that due to this convenient side effect of this drug the
deaths where misrepresented as covid when in fact they were murdered.

 

Can you provide any evidence to prove that this is not the case and these
people needed these medications and where given the correct amounts with
consent of relatives and thorough infornation provided about the use of
these drugs.”

 

CQC does not collect the data on medicines prescribed for individual
patients. If concerns are raised with us about a specific service, we will
take it into account when assessing risk, determining our regulatory
response and deciding what action needs to be taken. We also advise people
to raise their concerns directly with the service provider and, if they
believe a crime has been committed, with the police.

 

The Freedom of Information Act 2000

 

The purpose of FOIA is to ensure transparency and accountability in the
public sector. It seeks to achieve this by providing anyone, anywhere in
the world, with the right to access recorded information held by, or on
behalf of, a public authority.

 

Recorded information includes printed documents, computer files, letters,
emails, photographs, and sound or video recordings.

 

Public authorities spend money collected from taxpayers and make decisions
that can significantly affect many people’s lives. Access to information
helps the public make public authorities accountable for their actions and
allows public debate to be better informed and more productive.

 

The main principle behind FOIA is that people have a right to know about
the activities of public authorities, unless there is a good reason for
them not to.

 

A disclosure under FOIA is described as “applicant blind” meaning that it
is a disclosure into the public domain, not to any one individual.

 

This means that everyone has a right to access official information.
Disclosure should be the default – in other words, information should be
kept private only when there is a good reason and it is permitted by FOIA.

 

An applicant does not need to give a reason for wanting the information.
On the contrary, the public authority must justify refusing the
information.

 

Public authorities are required to treat all requests equally, except
under some limited circumstances. The information someone can access under
FOIA should not be affected by who they are, whether they are journalists,
local residents, public authority employees, or foreign researchers.

 

CQC Complaints and Internal Review procedure

 

If you are not satisfied with our handling of your request, then you may
request an internal review.

 

Please clearly indicate that you wish for a review to be conducted and
state the reason(s) for requesting the review.

 

Please note that it is usual practice to accept a request for an internal
review within 40 working days from the date of this response. The [4]FOIA
code of practice advises that public authorities are not obliged to accept
internal reviews after this date.

 

Please be aware that the review process will focus upon our handling of
your request and whether CQC have complied with the requirements of the
Freedom of Information Act 2000. The internal review process should not be
used to raise concerns about the provision of care or the internal
processes of other CQC functions.

 

If you are unhappy with other aspects of the CQC's actions, or of the
actions of registered providers, please see our website for information on
how to raise a concern or complaint:

 

[5]www.cqc.org.uk/contact-us

 

To request a review please contact:

 

Information Access

Care Quality Commission

Citygate

Gallowgate

Newcastle upon Tyne

NE1 4PA

 

E-mail: [6][CQC request email]

 

Further rights of appeal exist to the Information Commissioner’s Office
under section 50 of the Freedom of Information Act 2000 once the internal
appeals process has been exhausted.

 

The contact details are:

 

Information Commissioner's Office

Wycliffe House

Water Lane

Wilmslow

SK9 5AF

 

Telephone: 0303 123 1113

Website: [7]www.ico.org.uk

 

Kind regards

 

Information Access Officer

 

Telephone: 03000 616161

 

For information about CQC, including contact details, information about
how we use and protect personal data, and how to request information from
us, go to [8]https://www.cqc.org.uk/contact-us

 

-------------- The contents of this email and any attachments are
confidential to the intended recipient. They may not be disclosed to or
used by or copied in any way by anyone other than the intended recipient.
If this email is received in error, please notify us immediately by
clicking "Reply" and delete the email. Please note that neither the Care
Quality Commission nor the sender accepts any responsibility for viruses
and it is your responsibility to scan or otherwise check this email and
any attachments. Any views expressed in this message are those of the
individual sender, except where the sender specifically states them to be
the views of the Care Quality Commission. Information on how the Care
Quality Commission processes personal data is available here
http://www.cqc.org.uk/about-us/our-polic...

References

Visible links
1. https://www.cqc.org.uk/publications/them...
2. https://bnf.nice.org.uk/drug/midazolam.h...
3. https://cks.nice.org.uk/topics/coronavir...
4. https://assets.publishing.service.gov.uk...
5. http://www.cqc.org.uk/contact-us
6. mailto:[CQC request email]
7. http://www.ico.org.uk/
8. https://www.cqc.org.uk/contact-us